Abstract
People with chronic obstructive pulmonary disease, cardiovascular disease or hypertension have a high risk of severe coronavirus disease 2019 (COVID-19). Long-term exposure to air pollution, especially PM2.5, has also been associated with COVID-19 mortality. We collated individual-level data of confirmed COVID-19 cases during the first wave of the epidemic in mainland China. We fitted a generalized linear model using city-level COVID-19 cases and severe cases as the outcome, and long-term average levels of air pollutants as the exposure. Our analysis was adjusted using several variables, including a mobile phone dataset, covering human movement from Wuhan before the travel ban and movements within each city during the time of emergency response. Other variables included census, smoking prevalence, climate, and socio-economic data from 324 cities in China. We adjusted for human mobility and socio-economic factors, and found that an increase in long-term NO2 or PM2.5 may correspond to an increase in the number of COVID-19 cases and severe infections. However, the linkage might also be affected by the confounding factor of population size because of the predefined correlation between population size and air pollution. The results are derived from a large, newly compiled and geocoded repository of population and epidemiological data relevant to COVID-19. The findings of this paper (and other previous studies that have given ambiguous results) indicate that a more definitive analysis is needed of the link between COVID-19 and air pollution.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We thank the thousands of CDC staff and local health workers in China who collected data and continue to work to contain COVID-19 in China and elsewhere. Funding for this study was provided by the Research Council of Norway contributed to this work through the COVID-19 Seasonality Project (312740); Beijing Science and Technology Planning Project (Z201100005420010); National Natural Science Foundation of China (91643203, 81673234); Beijing Natural Science Foundation (JQ18025); Beijing Advanced Innovation Program for Land Surface Science; Young Elite Scientist Sponsorship Program by CAST (YESS) (2018QNRC001); H.T., M.U.G.K., and C.D. acknowledge support from the Oxford Martin School; HT acknowledges support from the Military Logistics Research Program. The funders had no role in study design, data collection and analysis, the decision to publish, or in the preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Beijing Normal University IRB
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We used a well-tested research data platform that gathers nationwide human mobility, census data, air pollution data, smoking data from a nationwide survey, and socio-economic data.
